Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme
Clinical trial NCT00544817 · COMPLETED
Trial details
- NCT number
- NCT00544817
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2008-06-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.